
Ozempic diabetes drug faces shortage after endorsements by celebs
Fox News
Danish drugmaker Novo Nordisk said the diabetes drug Ozempic is facing a shortage following "incredible demand" as well as the impact of global supply constraints.
Danish drugmaker Novo Nordisk said the 1 mg and 2 mg doses of Ozempic are currently available for patients nationwide. However, there are supply disruptions affecting the Ozempic pen that delivers 0.25 mg and 0.5 mg doses Julia Musto is a reporter for Fox News and Fox Business Digital.
"While we recognize that some healthcare providers may be prescribing Ozempic for patients whose goal is to lose weight, it is up to the clinical discretion of each healthcare provider to choose the best treatment approach for their patients," Novo Nordisk told Fox News Digital in a statement. "Novo Nordisk does not promote, suggest, or encourage off-label use of our medicines and is committed to fully complying with all applicable US laws and regulations in the promotion of our products. We trust that healthcare providers are evaluating a patient’s individual needs and determining which medicine is right for that particular patient."













